These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 38844744)

  • 1. Extracellular Vesicles in Cardiovascular Pathophysiology: Communications, Biomarkers, and Therapeutic Potential.
    Cui Z; Zhang L; Hu G; Zhang F
    Cardiovasc Toxicol; 2024 Aug; 24(8):711-726. PubMed ID: 38844744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicle interplay in cardiovascular pathophysiology.
    Saheera S; Jani VP; Witwer KW; Kutty S
    Am J Physiol Heart Circ Physiol; 2021 May; 320(5):H1749-H1761. PubMed ID: 33666501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicles in cardiovascular disease: Biological functions and therapeutic implications.
    Han C; Yang J; Sun J; Qin G
    Pharmacol Ther; 2022 May; 233():108025. PubMed ID: 34687770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Extracellular Vesicles As Biomarkers and Drug Delivery Vehicles in Cardiovascular Diseases.
    de Freitas RCC; Hirata RDC; Hirata MH; Aikawa E
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular vesicles in cardiovascular diseases: From pathophysiology to diagnosis and therapy.
    Du Y; Wu L; Wang L; Reiter RJ; Lip GYH; Ren J
    Cytokine Growth Factor Rev; 2023 Dec; 74():40-55. PubMed ID: 37798169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotective role of extracellular vesicles: A highlight on exosome beneficial effects in cardiovascular diseases.
    Rezaie J; Rahbarghazi R; Pezeshki M; Mazhar M; Yekani F; Khaksar M; Shokrollahi E; Amini H; Hashemzadeh S; Sokullu SE; Tokac M
    J Cell Physiol; 2019 Dec; 234(12):21732-21745. PubMed ID: 31140622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicles and cardiovascular system: Biomarkers and Cardioprotective Effectors.
    Femminò S; Penna C; Margarita S; Comità S; Brizzi MF; Pagliaro P
    Vascul Pharmacol; 2020 Dec; 135():106790. PubMed ID: 32861822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles.
    Davidson SM; Boulanger CM; Aikawa E; Badimon L; Barile L; Binder CJ; Brisson A; Buzas E; Emanueli C; Jansen F; Katsur M; Lacroix R; Lim SK; Mackman N; Mayr M; Menasché P; Nieuwland R; Sahoo S; Takov K; Thum T; Vader P; Wauben MHM; Witwer K; Sluijter JPG
    Cardiovasc Res; 2023 Mar; 119(1):45-63. PubMed ID: 35325061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles- crucial players in human pregnancy.
    Paul N; Sultana Z; Fisher JJ; Maiti K; Smith R
    Placenta; 2023 Sep; 140():30-38. PubMed ID: 37531747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolites as extracellular vesicle cargo in health, cancer, pleural effusion, and cardiovascular diseases: An emerging field of study to diagnostic and therapeutic purposes.
    Zhang Y; Liang F; Zhang D; Qi S; Liu Y
    Biomed Pharmacother; 2023 Jan; 157():114046. PubMed ID: 36469967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular Vesicles in Cardiovascular Theranostics.
    Bei Y; Das S; Rodosthenous RS; Holvoet P; Vanhaverbeke M; Monteiro MC; Monteiro VVS; Radosinska J; Bartekova M; Jansen F; Li Q; Rajasingh J; Xiao J
    Theranostics; 2017; 7(17):4168-4182. PubMed ID: 29158817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight into endothelial cell-derived extracellular vesicles in cardiovascular disease: Molecular mechanisms and clinical implications.
    Wang X; He B
    Pharmacol Res; 2024 Sep; 207():107309. PubMed ID: 39009292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging role of extracellular vesicles as a senescence-associated secretory phenotype: Insights into the pathophysiology of lung diseases.
    Kadota T; Fujita Y; Yoshioka Y; Araya J; Kuwano K; Ochiya T
    Mol Aspects Med; 2018 Apr; 60():92-103. PubMed ID: 29146100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular vesicles and their content in bioactive lipid mediators: more than a sack of microRNA.
    Boilard E
    J Lipid Res; 2018 Nov; 59(11):2037-2046. PubMed ID: 29678959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-omics analysis identified extracellular vesicles as biomarkers for cardiovascular diseases.
    Meng K; Meng F; Wu Y; Lin L
    Talanta; 2024 Dec; 280():126710. PubMed ID: 39213888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular Vesicles: New Endogenous Shuttles for miRNAs in Cancer Diagnosis and Therapy?
    Martellucci S; Orefice NS; Angelucci A; Luce A; Caraglia M; Zappavigna S
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the regulatory mechanisms of extracellular vesicles-mediated intercellular communication.
    Liu YJ; Wang C
    Cell Commun Signal; 2023 Apr; 21(1):77. PubMed ID: 37055761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicles: Potential impact on cardiovascular diseases.
    Yang J; Zou X; Jose PA; Zeng C
    Adv Clin Chem; 2021; 105():49-100. PubMed ID: 34809830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicles: Novel mediator for cell to cell communications in liver pathogenesis.
    Devhare PB; Ray RB
    Mol Aspects Med; 2018 Apr; 60():115-122. PubMed ID: 29122679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles in obesity and diabetes mellitus.
    Pardo F; Villalobos-Labra R; Sobrevia B; Toledo F; Sobrevia L
    Mol Aspects Med; 2018 Apr; 60():81-91. PubMed ID: 29175307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.